Tesamorelin 20 mg

穩定化的生長激素釋放激素類似物，文獻關注其對內臟脂肪組織及 IGF-1 軸活性的影響（研究模型）。

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

作用機制

文獻關注其選擇性結合 GHRH 受體並具有延長半衰期。研究與研究族群內臟脂肪指標降低及 IGF-1 升高相關。